Technical analysis of Lexeo Therapeutics, Inc. Common Stock (LXEO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates.
Price Performance
| 1 month | -15.62% |
| 3 months | -15.62% |
| Year-to-date | -58.11% |
| 1 year | -22.39% |
52-Week Range
| 52-week High | $10.99 |
| 52-week Low | $3.99 |
| Avg Volume (90d) | 882K |
Technical Indicators
| SMA 50 | $4.69 |
| SMA 200 | $6.22 |
| Beta | 2.00 |
| 30-day Volatility (annualised) | 50.9% |
| Price vs SMA 50 | -11.3% |
| Price vs SMA 200 | -33.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $10.01 | |
| 2025-11 | $9.86 | -1.5% |
| 2025-12 | $9.93 | +0.7% |
| 2026-01 | $7.41 | -25.4% |
| 2026-02 | $7.18 | -3.1% |
| 2026-03 | $5.74 | -20.1% |
| 2026-04 | $5.70 | -0.7% |
| 2026-05 | $5.14 | -9.8% |
| 2026-06 | $4.66 | -9.3% |
| 2026-07 | $4.13 | -11.4% |
| 2026-08 | $4.76 | +15.3% |
| 2026-09 | $4.16 | -12.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $144M |
| 2026-09-14 | | $898M |
Price
| Price | $4.16 |
| Market Cap | $327M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.52 |
| EV / EBITDA | -3.00 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.03 |
| Current Ratio | 13.89 |